FDA

Study will focus on effects of CBD and CBG for canine elbow osteoarthritis

Funding intended to improve the animal food ingredient review and approval process as well as developing regulations for ingredient claims

Dechra’s alpha-2 combination drug is indicated to minimize stress surrounding canine sedation

This chewable tablet is the first drug on the market for delaying the onset of Stage B2 preclinical myxomatous mitral valve disease in canines

Pharmaceutical sponsors who meet the eligibility requirements or their research partners are encouraged to apply.

Tulathromycin injection is an option for bovine respiratory disease, and other conditions

The new dry cat food that will alleviate feline hairballs is now available in stores

Jaguar Animal Health’s crofelemer product has conditional approval from the FDA

The document expands upon the original guidance #106 by considering various uses of the scientific literature to support approval of a new animal drug

3 articles highlighting the latest FDA-approved veterinary drugs

The drug product is a balanced combination of medetomidine and vatinoxan.

The new drug product is indicated for dogs with pain and inflammation associated with osteoarthritis, and postoperative pain and inflammation associated with soft-tissue and orthopedic surgery.

The new prescription drugs from Merck Animal Health are broad-spectrum medications for combating organisms that cause the illness.

Crofelemer (Canalevia-CA1) is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs and could also be used to treat exercise-induced diarrhea.

Frunevetmab injection (Zoetis; Solensia) is the first treatment for pain associated with osteoarthritis in cats.

Antimicrobial stewardship has taken the human health world by storm, and now, it’s securing its place in veterinary medicine.